课题基金 / 基金详情

Investigation for the possibility of CaMKII activity modulation for the therapeutic optical in rheumatoid arthritis

Investigation for the possibility of CaMKII activity modulation for the therapeutic optical in rheumatoid arthritis
CaMKII 活性调节用于类风湿性关节炎治疗光学的可能性的研究
批准号:
18591116
负责人:
KAWAKAMI Atsushi
金额:
$2.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

KAWAKAMI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The remarkable proliferation as well as apoptosis resistance are crucial for rheumatoid arthritis (RA). Among them, we have focused on the importance of PI3K/Akt pathway, and in the current 2 years, we have tried to investigate the role of CaMKII pathway. FLS in culture expressed CaMKII γ and δ, especially δ isoform. The addition of CaMKII chemical inhibitor, KN93, significantly augmented apoptosis sensitivity of FLS in response to TRAIL and anti-Fas antibody. The additional experiment showed that CaMKII-induced phenomena of apoptosis sensitivity are mediated through Akt. CaMKII is an enzyme that is activated by Ca ion influx. Ca ion influx also activates PADI, which is an essential enzyme for post-transcriptional mechanism of peptide citrullination. Post-transcriptional mechanism of peptide citrullination is thought to be crucial for anti-CCP antibodies production in patients with RA, a RA-specific autoantibodies. However, we could not detect the citrullinated peptides in cultured FLS in response to Ca ion influx, pro-inflammatory cytoltines or pro-apoptotic stimuli. Thus, we conducted the experiment by the use of human cell line, HL-60. HL-60 expressed CaMKII γ isoform. A significant expression of PADI4, citrullinated peptides and Akt phosphorylation was found during the course of granulocyte-lineage differentiation of HL-60 by ATRA According to the results obtained in the current 2 years, an association between CaMKII and FLS apoptosis is demonstrated. Considering a possible cross-talk between CaMKII and Akt, another cross-talk among CaMKII, Akt and the peptide citrullination process appears to be present. These mechanisms are thought to be important research issue of RA that strengthens a role of CaMKII for a target molecule in RA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EGF activates PI3K-Akt and NF-kappaB via distinct pathways in salivary epithelial cells in Sjogren's syndrome
EGF 通过干燥综合征唾液上皮细胞中的不同途径激活 PI3K-Akt 和 NF-kappaB
DOI: --
发表时间: 2007
期刊: Rheumatology international 28(2)
影响因子: --
作者: [Nakamura H, Kawakami A, Eguchi K(2番目, 他2名)]
通讯作者: 他2名)
DOI: --
发表时间: 2006
期刊: Translafional Res 148(6)
影响因子: --
作者: [Nakamura H, Kawakami A, Eguchi K]
通讯作者: Eguchi K
関節リウマチの早期診断と早期からの骨病変進展予測の試み
类风湿关节炎早期诊断和骨病变进展早期预测的尝试
DOI: --
发表时间: 2006
期刊: 臨床リウマチ 18(4)
影响因子: --
作者: [川上 純, 江口 勝美(1番目, 他7名)]
通讯作者: 他7名)
関節リウマチに対するinfliximabの長期治療効果と安全性:102週での検討
英夫利昔单抗治疗类风湿关节炎的长期疗效和安全性:102 周研究
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Kawakami A(筆頭著者, 他13名), Tamai M, Tamai M, 玉井 慎美, 岩本 直樹, 玉井 慎美, 岩本 直樹, 中村 英樹, 有馬 和彦, 玉井 慎美, 藤川 敬太, 荒牧 俊幸, 右田 清志, 荒牧 俊幸, 藤川 敬太, 玉井 慎美, 岩永 希, 折口 智樹, 岩永 希]
通讯作者: 岩永 希
70
    Basic research for searching of new therapeutic targets of rheumatoid arthritis through investigation of novel action of CTLA-4-Ig
    • 批准号:
      15K09531
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    Investigation of autoantigens in patients with rheumatoid arthritis through protemic analysis: exploration from diagnosis, pathogenesis to therapy
    • 批准号:
      23591439
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    Cell and signal mechanisms that support tissue regeneration in fish
    • 批准号:
      21570004
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    Can we explain the varying pathologic processes of rheumatoid arthritis by CaMKII delta abnormality?
    • 批准号:
      20591173
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      KAWAKAMI Atsushi
    • 依托单位:
    国内基金
    海外基金
    土家药血筒三萜调控Sema4D/PlexinB1信号轴抑制功能细胞串扰抗RA的机制研究
    • 批准号:
      2026JJ80908
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      余黄合
    • 依托单位:
    基于“大气下陷”理论探讨升陷汤调控IL-17A/IL-17RA信号轴抑制MMP-2/MMP-9表达抗心衰大鼠心肌纤维化的作用机制
    • 批准号:
      2026JJ80502
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王雪
    • 依托单位:
    通痹颗粒抑制糖代谢重编程调控巨噬细胞极化治疗RA的机制研究
    基于质谱成像及巨噬细胞糖代谢重编程研究土家药血筒总三萜抗RA作用机制
    • 批准号:
      2026JJ50633
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      袁汉文
    • 依托单位: